English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 11 June 2020, 05:00 HKT/SGT
Share:
    

Source: Agilex Biolabs
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020

Adelaide, AUS, June 11, 2020 - (ACN Newswire) - Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020.

Watch the BIO Digital 2020 presentation here:
https://www.bio.org/events/bio-digital/sessions/search?name=Agilex

The presentation by CEO Jason Valentine and moderated by VP Business Development Julia Jones details the current trials landscape in Australia and why biotechs wanting to avoid delays caused by COVID-19, can move their trials to Australia.

Australia's impressive COVID-19 management and the world's most attractive rebate on clinical trials costs are just a few of the reasons that make it an ideal location to restart delayed trials, according to Agilex Biolabs.

CEO Jason Valentine said:

"Australia has a group of proven top-tier trial providers that regularly work together so are fully engaged and in sync with processes and each other's requirements and capabilities. We have worked with all the trials service provider companies so can advise on which ones are the best fit for each study.

"The Agilex Biolabs team can offer an unbiased approach and advice depending on specific trial requirements. Our world-class bioanalytical facilities have OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition."

Please Book a Briefing with us before you start your next clinical trial. https://calendly.com/agilexbiolabs/15min

Australia: +61 8 8302 8777 | China: +86 21 8036 9483 | South Korea: +82 80 812 1255 | USA: +1 800 247 1909

Agilex Biolabs has launched a News Video Update about COVID-19 and clinical trials in Australia. Watch it here: https://youtu.be/vZuHAYZ-GiE


About Agilex Biolabs https://www.agilexbiolabs.com

Agilex Biolabs, Australia's leading bioanalytical laboratory, has more than 20 years' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services. We have successfully supported hundreds of preclinical and clinical trials around the world where customers choose Australia for the streamlined regulatory process and access to the world's most attractive R&D rebate of more than 40% on clinical trial work conducted in Australia.

Agilex Biolabs specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gurolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser). Agilex offers pharmacodynamics services including immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, incuding Immunophenotyping, Receptor occupancy, and Cytokine release assays (whole blood or PBMC stimulation assays) and cytokine/biomarker profiling PBMC assays and cellular mechanism of action assays (ie ADCC).

Agilex Biolabs, the only FDA-inspected lab of its type in the region, is located in Adelaide, South Australia in a science and biotech specialist hub. The biolabs has more than 65 dedicated laboratory staff, and annually support more than 80 clinical trials. This year they will analyse more than 60,000 samples for pharma/biotechs from US, Europe and APAC.
The company has just expanded its labs by more than 30% to accommodate biotech demand from APAC and the USA.

See us featured in Endpoints https://tinyurl.com/uqmkzcu

Media Contact:
Kate Newton
[email protected]


Topic: Press release summary
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Agilex Biolabs Releated News
July 22, 2020 06:00 HKT/SGT
Agilex Biolabs和Endpoints News推出“如何将试验转移到澳大利亚”网络研讨会
July 22, 2020 06:00 HKT/SGT
Agilex Biolabs和Endpoints News推出“如何將試驗轉移到澳大利亞”網絡研討會
July 22, 2020 06:00 HKT/SGT
애질렉스 바이오랩스와 엔드포인츠 뉴스, ‘호주로의 임상 시험 이전’ 웨비나 공동개최
July 22, 2020 06:00 HKT/SGT
Agilex Biolabs and Endpoints News Present 'How to Move Trials to Australia' Webinar
May 21, 2020 09:00 HKT/SGT
애질렉스 바이오랩스, 바이오코리아(BIO Korea) 2020에서 임상 시험 비용에 대한 세계 최대 규모 리베이트 등 호주의 강점 선보일 예정
More news >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575